Showing results (11-20 of 223) with videos related to

Sort By:
Pageof 23
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 4, 2015
PP2A inhibition as a novel therapeutic target in castration-resistant prostate cancerPaula González-Alonso, Ion Cristóbal, Rebeca Manso, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 17, 2017
PP2A regulates signaling through hormonal receptors in breast cancer with important therapeutic implicationsIon Cristóbal, Blanca Torrejón, Javier Martínez-Useros, et al.
Current Medical Research and Opinion|March 8, 2016
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief reviewIon Cristóbal, Juan Madoz-Gúrpide, Rebeca Manso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cellsJudit Anido, Pablo Matar, Joan Albanell, et al.
BMC Pulmonary Medicine|October 28, 2015
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancerCristina Chamizo, Sandra Zazo, Manuel Dómine, et al.
Cancer Treatment and Research Communications|May 25, 2025
New therapeutic approaches for EGFR mutated non-small cell lung cancer on osimertinib eraJaime Rubio-Perez, Roberto Hernandez, Carlota Santolaya, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 25, 2007
Expression of DNA damage checkpoint protein Hus1 in epithelial ovarian tumors correlates with prognostic markersJavier de la Torre, Antonio Gil-Moreno, Angel García, et al.
Cancer|September 20, 2006
Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancerJosep Castellvi, Angel Garcia, Federico Rojo, et al.
Cancers|February 15, 2022
Update on Management Recommendations for Advanced Cutaneous Squamous Cell CarcinomaJesús García-Foncillas, Antonio Tejera-Vaquerizo, Onofre Sanmartín, et al.
Cancer Research|February 21, 2006
Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicityFrederick Y Wu, Shizhen Emily Wang, Melinda E Sanders, et al.
Pageof 23